Your email has been successfully added to our mailing list.

×
0 0 0 0 0 0 0.0131470829909614 0.0137633525061627
Stock impact report

Acceleron Appoints Global Innovation and Drug Development Executive Kemal Malik, MB BS, to its Board of Directors

Acceleron Pharma, Inc (XLRN)  More Company Research Source: Business Wire
Last acceleron pharma, inc earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.acceleronpharma.com/investor-relations
PDF CAMBRIDGE, Mass.--(BUSINESS WIRE)--Acceleron Pharma Inc. (Nasdaq:XLRN), a leading biopharmaceutical company in the discovery and development of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today the appointment of Kemal Malik, MB BS, to its Board of Directors. Dr. Malik, who is currently a member of the Board of Management of Bayer AG, will officially join the Acceleron Board effective January 1, 2020.“We’re thrilled to be able to add an individual of Kemal’s caliber to the Acceleron Board,” said Francois Nader, M.D., Chairman of Acceleron Pharma. “His global development and innovation experience across a range of therapeutic areas should prove enormously valuable in helping to guide Acceleron through its exciting transition from a clinical-stage organization to a fully-integrated biopharmaceutical company.”Dr. Malik has served on the Board of Management of Bayer AG since 2014, with responsibility for Innovation across the Bayer group. His career [Read more]
Impact snapshot Event time: XLRN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last price
VWAP
High:
Max up
High:
Low:
Max down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Opt-in for
XLRN alerts
from News Quantified
Opt-in for
XLRN alerts

from News Quantified
Opt-in for
XLRN alerts

from News Quantified